Jafron Biomedical Co Ltd (300529) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.010x

Based on the latest financial reports, Jafron Biomedical Co Ltd (300529) has a cash flow conversion efficiency ratio of 0.010x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥35.34 Million ≈ $5.17 Million USD) by net assets (CN¥3.43 Billion ≈ $501.72 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Jafron Biomedical Co Ltd's balance sheet to measure how much of total assets are equity-financed.

Jafron Biomedical Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Jafron Biomedical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Jafron Biomedical Co Ltd to evaluate the quality of earnings relative to operating cash generation.

Jafron Biomedical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jafron Biomedical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
GCL System Integration Technology Co Ltd SHE:002506	0.162x
Shandong Iron and Steel Co Ltd SHG:600022	0.016x
Zhejiang Shenghua Biok Biology Co Ltd SHG:600226	0.021x
Remy Cointreau PA:RCO	0.002x
Shandong Shida Shenghua Chem SHG:603026	0.029x
Royce Value Closed Fund NYSE:RVT	0.001x
Evolution Metals & Technologies Corp. Common Stock NASDAQ:EMAT	0.018x
Liontown Resources Ltd AU:LTR	-0.071x

Annual Cash Flow Conversion Efficiency for Jafron Biomedical Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Jafron Biomedical Co Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see 300529 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥3.47 Billion ≈ $507.96 Million	CN¥721.22 Million ≈ $105.54 Million	0.208x	-34.08%
2024-12-31	CN¥3.33 Billion ≈ $487.97 Million	CN¥1.05 Billion ≈ $153.79 Million	0.315x	+8.39%
2023-12-31	CN¥3.15 Billion ≈ $461.36 Million	CN¥916.74 Million ≈ $134.15 Million	0.291x	+18.12%
2022-12-31	CN¥3.59 Billion ≈ $525.40 Million	CN¥883.80 Million ≈ $129.33 Million	0.246x	-33.34%
2021-12-31	CN¥3.38 Billion ≈ $495.13 Million	CN¥1.25 Billion ≈ $182.83 Million	0.369x	+9.28%
2020-12-31	CN¥2.83 Billion ≈ $414.65 Million	CN¥957.49 Million ≈ $140.11 Million	0.338x	+25.70%
2019-12-31	CN¥2.17 Billion ≈ $317.62 Million	CN¥583.50 Million ≈ $85.38 Million	0.269x	+20.52%
2018-12-31	CN¥1.72 Billion ≈ $251.97 Million	CN¥384.08 Million ≈ $56.20 Million	0.223x	+2.07%
2017-12-31	CN¥1.39 Billion ≈ $203.62 Million	CN¥304.10 Million ≈ $44.50 Million	0.219x	+44.85%
2016-12-31	CN¥1.18 Billion ≈ $173.26 Million	CN¥178.64 Million ≈ $26.14 Million	0.151x	-58.52%
2015-12-31	CN¥564.06 Million ≈ $82.54 Million	CN¥205.18 Million ≈ $30.02 Million	0.364x	+19.81%
2014-12-31	CN¥452.42 Million ≈ $66.20 Million	CN¥137.35 Million ≈ $20.10 Million	0.304x	-13.44%
2013-12-31	CN¥380.12 Million ≈ $55.62 Million	CN¥133.33 Million ≈ $19.51 Million	0.351x	-15.17%
2012-12-31	CN¥290.84 Million ≈ $42.56 Million	CN¥120.25 Million ≈ $17.60 Million	0.413x	+15.66%
2011-12-31	CN¥215.57 Million ≈ $31.54 Million	CN¥77.06 Million ≈ $11.28 Million	0.357x	--

About Jafron Biomedical Co Ltd

SHE:300529 China Medical Devices

Market Cap

$2.17 Billion

CN¥14.85 Billion CNY

Market Cap Rank

#5806 Global

#1065 in China

Share Price

CN¥18.60

Change (1 day)

+0.38%

52-Week Range

CN¥15.04 - CN¥24.54

All Time High

CN¥96.12